MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 28.04.2026
OPKO Health Kurzfristige Verbindlichkeiten 2011-2026 | OPK
Kurzfristige Verbindlichkeiten Jährlich OPKO Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 193 M | 200 M | 213 M | 330 M | 375 M | 249 M | 288 M | 312 M | 263 M | 252 M | 83.1 M | 91.8 M | 52.4 M | 18.8 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 375 M | 18.8 M | 209 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K |  USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.28 B | $ 201.02 | -1.01 % | $ 22.3 B | USA |
 |
Celcuity
CELC
|
44.2 M | $ 88.17 | -0.43 % | $ 4.12 B | USA |
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
3.54 M | $ 3.93 | -8.39 % | $ 5.23 M | USA |
 |
Fulgent Genetics
FLGT
|
85 M | $ 18.54 | -0.75 % | $ 571 M | USA |
 |
Castle Biosciences
CSTL
|
68.7 M | $ 20.56 | -0.68 % | $ 596 M | USA |
 |
Aspira Women's Health
AWH
|
3.46 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
31.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Interpace Biosciences
IDXG
|
5.1 M | $ 1.65 | 3.12 % | $ 7.3 M | USA |
 |
Illumina
ILMN
|
1.58 B | $ 164.39 | 2.12 % | $ 25.5 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Guardant Health
GH
|
303 M | $ 129.45 | -1.65 % | $ 16.2 B | USA |
 |
CareDx, Inc
CDNA
|
89.8 M | $ 22.98 | 0.04 % | $ 1.22 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
4.05 M | - | - | $ 9.42 M |  Israel |
 |
ICON Public Limited Company
ICLR
|
3.2 B | $ 146.18 | - | $ 11.5 B |  Irlanda |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
NeoGenomics
NEO
|
88.3 M | $ 11.09 | -0.54 % | $ 1.42 B | USA |
 |
National Research Corporation
NRC
|
36.6 M | $ 18.35 | -2.34 % | $ 411 M | USA |
 |
Natera
NTRA
|
441 M | $ 214.4 | 1.1 % | $ 29.3 B | USA |
 |
Lantheus Holdings
LNTH
|
333 M | $ 103.97 | -0.53 % | $ 7.02 B | USA |
 |
Charles River Laboratories International
CRL
|
1.12 B | $ 189.74 | 1.19 % | $ 9.4 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
72.8 M | $ 1.37 | 4.2 % | $ 411 M | USA |
 |
Medpace Holdings
MEDP
|
1.34 B | $ 467.9 | 0.12 % | $ 13.5 B | USA |
 |
Exact Sciences Corporation
EXAS
|
641 M | - | - | $ 19.8 B | USA |
 |
Mettler-Toledo International
MTD
|
1.2 B | $ 1 142.32 | 0.96 % | $ 23.5 B |  Schweiz |
 |
Myriad Genetics
MYGN
|
134 M | $ 4.29 | -0.92 % | $ 397 M | USA |
 |
Personalis
PSNL
|
39.6 M | $ 9.8 | 2.19 % | $ 875 M | USA |
 |
Senseonics Holdings
SENS
|
24.3 M | $ 7.28 | 1.35 % | $ 304 M | USA |
 |
Twist Bioscience Corporation
TWST
|
91.4 M | $ 79.83 | 4.81 % | $ 4.77 B | USA |
 |
QIAGEN N.V.
QGEN
|
512 M | - | - | $ 10.6 B |  Niderland |
 |
Soleno Therapeutics
SLNO
|
61.4 M | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.03 | -1.22 % | $ 4.66 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
2.82 B | $ 263.98 | -0.82 % | $ 22 B | USA |
 |
Thermo Fisher Scientific
TMO
|
15.2 B | $ 469.74 | 0.19 % | $ 177 B | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
174 M | $ 9.13 | 0.33 % | $ 1.98 B | USA |
 |
Invitae Corporation
NVTA
|
108 M | - | - | $ 21.2 M | USA |